The largest and most comprehensive study of its kind, The Human Trisome Project will help us understand why individuals with Down syndrome (trisomy 21) are protected from some medical conditions, such as cancer, while highly predisposed to others, such as Alzheimer’s disease.

 

This research will serve first and foremost the population with Down syndrome, but also the millions of individuals without Down syndrome who are affected by the many medical conditions modulated by trisomy 21.

 

We are currently enrolling anyone 6 months to 89 years old who: 1) has Down syndrome (any type) 2) has a family member with Down syndrome 3) is a healthy individual without Down syndrome. Click here to view The Human Trisome Project Biobank flyer for more information. Interested? Contact us at 303-724-7366 and htp@ucdenver.edu.